MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

Search

VistaGen Therapeutics Inc

Suletud

2.28 -3.8

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

2.28

Max

2.38

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+404.2% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

12. aug 2025

VistaGen Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

14. juuli 2025, 22:07 UTC

Suurimad hinnamuutused turgudel

Trade Desk Rises on S&P 500 Inclusion

14. juuli 2025, 17:06 UTC

Suurimad hinnamuutused turgudel

Crypto Assets Rally Ahead of Possible U.S. Legislation

14. juuli 2025, 16:47 UTC

Omandamised, ülevõtmised, äriostud

NatWest to Sell Stake in Permanent TSB

14. juuli 2025, 23:46 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

14. juuli 2025, 23:38 UTC

Market Talk

Gold Edges Higher Ahead of U.S. CPI Data -- Market Talk

14. juuli 2025, 23:37 UTC

Market Talk

ANZ's Institutional Earnings Likely to Weigh on Outlook -- Market Talk

14. juuli 2025, 23:29 UTC

Market Talk

South32 Bull Eyes Possible Last-Minute Power Deal for Mozal -- Market Talk

14. juuli 2025, 23:29 UTC

Market Talk

Global Energy Roundup: Market Talk

14. juuli 2025, 23:02 UTC

Tulu

China Vanke: Additional Provision for Asset Impairment Also Among Factors Weighing on Results >000002.SZ

14. juuli 2025, 23:02 UTC

Tulu

China Vanke: Weakness in Overall China Real-Estate Sector Weighed on Results >000002.SZ

14. juuli 2025, 23:02 UTC

Tulu

China Vanke 1H Loss Was CNY9.85B >000002.SZ

14. juuli 2025, 23:01 UTC

Tulu

China Vanke Sees 1H Loss CNY10.0B-Loss CNY12.0B >000002.SZ

14. juuli 2025, 23:01 UTC

Tulu

China Vanke Expects 1H Loss to Widen >000002.SZ

14. juuli 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

14. juuli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14. juuli 2025, 20:07 UTC

Market Talk

Cloud Computing Giants Will Be the Winner from Software's Loss -- Market Talk

14. juuli 2025, 20:05 UTC

Market Talk

Adobe and Salesforce May Struggle to Keep Up With AI Agents -- Market Talk

14. juuli 2025, 19:11 UTC

Market Talk

Oil Retreats Despite Trump Threats of Russia Sanctions -- Market Talk

14. juuli 2025, 19:09 UTC

Market Talk

Gold Breaks a 3-Day Win Streak -- Market Talk

14. juuli 2025, 18:59 UTC

Market Talk

Hotter Weather Outlook, LNG Flows Boost U.S. Natural Gas -- Market Talk

14. juuli 2025, 18:30 UTC

Omandamised, ülevõtmised, äriostud

Synopsys Buy of Ansys Gets China OK. The $35 Billion Deal Is Set to Close. -- Barrons.com

14. juuli 2025, 18:25 UTC

Market Talk

Dollar Gains, Treasury Yields Lose Steam as Trump Threatens Russia -- Market Talk

14. juuli 2025, 18:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14. juuli 2025, 16:59 UTC

Market Talk

Goldman Sachs Lifts 2H25 Crude Price Views -- Market Talk

14. juuli 2025, 16:53 UTC

Kuumad aktsiad

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14. juuli 2025, 16:27 UTC

Market Talk

Oil Falls as Investors Monitor U.S.-EU Trade, Trump's Russia Sanction Threats -- Market Talk

14. juuli 2025, 16:20 UTC

Market Talk
Tulu

Auto & Transport Roundup: Market Talk

14. juuli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

14. juuli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

14. juuli 2025, 16:12 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

Võrdlus sarnastega

Hinnamuutus

VistaGen Therapeutics Inc Prognoos

Hinnasiht

By TipRanks

404.2% tõus

12 kuu keskmine prognoos

Keskmine 12 USD  404.2%

Kõrge 12 USD

Madal 12 USD

Põhineb 2 Wall Streeti analüütiku instrumendi VistaGen Therapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

2

Osta

0

Hoia

0

Müü

Finantsandmed

$